Discovery of di-indolinone as a novel scaffold for protein tyrosine phosphatase 1B inhibitors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2012-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2012.10.054PMID 23122522
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

  2012cited by this paper
• Synthesis and biological evaluation of novel indolin-2-one derivatives as protein tyrosine phosphatase 1b inhibitors

  2011cited by this paper
• Discovery of Orally Active, Potent, and Selective Benzotriazole‐Based PTP1B Inhibitors

  2011cited by this paper
• Click to a focused library of benzyl 6-triazolo(hydroxy)benzoic glucosides: novel construction of PTP1B inhibitors on a sugar scaffold.

  2011cited by this paper
• Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors.

  2010cited by this paper
• Studies on two types of PTP1B inhibitors for the treatment of type 2 diabetes: Hologram QSAR for OBA and BBB analogues.

  2010cited by this paper
• Novel thiazolidinedione derivatives with anti-obesity effects: dual action as PTP1B inhibitors and PPAR-γ activators.

  2010cited by this paper
• Use of protein tyrosine phosphatase inhibitors as promising targeted therapeutic drugs.

  2009cited by this paper
• Discovery of a novel competitive inhibitor of PTP1B by high-throughput screening

  2008cited by this paper
• Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors.

  2008cited by this paper
• Facile Synthesis of Various Nitro-Substituted Derivatives of Semaxinib (SU5416)

  2008cited by this paper
• Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.

  2008cited by this paper
• Protein tyrosine phosphatases: from genes, to function, to disease

  2006cited by this paper
• Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake.

  2006cited by this paper
• Coordinated Regulation of Insulin Signaling by the Protein Tyrosine Phosphatases PTP1B and TCPTP

  2005cited by this paper
• Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.

  2005cited by this paper
• Discovery of novel PTP1b inhibitors.

  2004cited by this paper
• Protein tyrosine phosphatase 1B inhibitors for diabetes

  2002cited by this paper
• Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice

  2000cited by this paper
• Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B*

  2000cited by this paper
• Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

  1999cited by this paper
• Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.

  1998cited by this paper
• Crystal structure of human protein tyrosine phosphatase 1B.

  1994cited by this paper
• Stereochemistry and photoisomerisation of furfurylideneoxindoles

  1977cited by this paper

• Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.

  2022cites this paper
• Computational Methods in Cooperation with Experimental Approaches to Design Protein Tyrosine Phosphatase 1B Inhibitors in Type 2 Diabetes Drug Design: A Review of the Achievements of This Century

  2022influential citation
• Update of Indoles: Promising molecules for ameliorating metabolic diseases.

  2022cites this paper
• Green Synthesis of Fluorescent Peptidomimetic Triazoles from Biomass-Derived 5-(Chloromethyl)furfural

  2018cites this paper
• Synthesis of Imines and Amines from Furfurals Using Continuous Flow Processing

  2017cites this paper
• Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.

  2016cites this paper
• In vitro and in silico evaluation of twelve newly-synthesized 1-acetamide-5-methoxy-2-oxindoles as 5-Ht₇ receptor ligands.

  2015cites this paper
• Iodine‐Mediated Oxidation of Ynamides: A Facile Access to N‐Monosubstituted α‐Ketoamides and α‐Ketoimides

  2014cites this paper
• Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.

  2014cites this paper
• Chemical-catalytic approaches to the production of furfurals and levulinates from biomass.

  2014cites this paper
• Regiospecific synthesis of 1-acetamide-5-methoxy-2-oxindoles in two steps: (Ugi-SN2)/xanthate mediated free radical cyclization

  2014cites this paper
• 1H-2,3-Dihydroperimidine Derivatives: A New Class of Potent Protein Tyrosine Phosphatase 1B Inhibitors

  2013cites this paper
• Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.

  2013cites this paper